HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
Balancing interoperability with patient privacy in 2023
Digital Checkup

Balancing interoperability with patient privacy in 2023

18:03

Rita Bowen, a member of the Sequoia Project board of directors and MRO vice president, discusses data usability, harmonizing HIPAA with interoperability, third-party compliance and highly sensitive data.

Read More
Read Less

Digital Checkup - Similar Videos View more in Digital Checkup

5:46

WISeR model is an attempt by CMS to reduce spending in Medicare

CMS says about 25% of the spend is fraudulent or being abused by providers, says Carol Howard, vice president of innovation and adoption at Janus Health.

WISeR model is an attempt by CMS to reduce spending in Medicare
CMS says about 25% of the spend is fraudulent or being abused by providers, says Carol Howard, vice president of innovation and adoption at Janus Health.
5:46
6:26

Lirio blends behavioral science and AI personalization

Marten den Haring, CEO of Lirio, says the company uses its Large Behavior Model, which blends behavioral science with artificial intelligence, with the goal of driving consumer engagement in healthcare at the personal level.

Lirio blends behavioral science and AI personalization
Marten den Haring, CEO of Lirio, says the company uses its Large Behavior Model, which blends behavioral science with artificial intelligence, with the goal of driving consumer engagement in healthcare at the personal level.
6:26
4:40

AION Labs to explore quantum tech

Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.

AION Labs to explore quantum tech
Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.
4:40